Infectious Diseases
Mary Kay Inc. & European Society for Dermatological Research Partner to Award Educational Research Grants Advancing Skin Health/Skin Disease
17/05/2023 — DALLAS — (BUSINESS WIRE) Mary Kay Inc., a global leader in skin care innovation, in partnership with the European Society for Dermatological Research, recently announced its inaugural Mary […]
Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
11/04/2023 — ATLANTA — (BUSINESS WIRE) Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory […]
Partnership to Fight Infectious Disease Launches European Chapter
Antimicrobial Resistance is Set to Become the Next Public Health Emergency 15/12/2022 — BRUSSELS — (BUSINESS WIRE) Infections due to antimicrobial resistance (AMR) are a significant threat to modern healthcare […]
Alliance Healthcare and GIRP, the European Healthcare Distribution Association, Host Antimicrobial Resistance (AMR) Event
Inaugural event brings together leaders across the pharmaceutical and healthcare industries to facilitate collaboration, best-practice sharing and discussions on initiatives to address AMR 17/11/2022 — BRUSSELS — (BUSINESS WIRE) Alliance […]
Freestyle Partners Receives Two European Patents for Use of Filtered Far UV-C Light in Handheld Devices
07/11/2022 — DETROIT — (BUSINESS WIRE) Freestyle Partners, LLC, announced today that it has received a Notice of Intent to Grant for two additional patents from the European Patent Office […]
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Study results were included in the submission to Health Canada leading to Notice of Compliance 05/05/2022 — QUEBEC CITY — (BUSINESS WIRE) Medicago today announced the publication of the results […]
Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Support U.S. Public Health Initiatives
INNOVATIVE RESPONSE SUPPORTS FUTURE RESPONSES AGAINST SIMILAR PANDEMIC THREATS First results from the CDC SARS-CoV-2 U.S. variant surveillance program to be published Positive COVID samples sequenced for variant surveillance in […]
Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere
– Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic – 28/03/2022 — FOSTER CITY, Calif. — (BUSINESS WIRE) Gilead Sciences, Inc., (Nasdaq: GILD) today […]
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
A vaccine manufactured in plants and developed in Canada 24/02/2022 — QUEBEC CITY & LONDON — (BUSINESS WIRE) Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today […]
Omicron and Travel: Travelner Advises How to Find the Best Online Travel Insurance
10/02/2022 — LONDON — (BUSINESS WIRE) The pandemic in general, and the outbreak of Omicron recently, have created a much broader awareness of travel insurance. “What happens if I get […]
Humanigen Launches Managed Access Program for Lenzilumab
10/02/2022 — BURLINGAME, Calif. & DUBLIN & LONDON — (BUSINESS WIRE) Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ […]
Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate
Final portion of data submitted as part of New Drug Submission for COVID rolling review COVID-19 vaccine candidate fully developed in Canada submitted for authorization 16/12/2021 — QUEBEC CITY — […]
Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3% efficacy […]
The Lancet Respiratory Medicine Publishes Peer-Reviewed Paper and Independent Expert Commentary on Positive Phase 3 Lenzilumab Results
Lenzilumab is a variant-agnostic therapeutic that targets the dysregulated host immune response, an approach which may be of greater value than targeting the virus in hospitalized patients1 Per the paper, […]
European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19
Ten most promising treatments for COVID-19 identified by the European Commission’s independent experts as having “the highest potential impact on the pandemic”* European Commission’s independent panel of 10 experts across […]
Adagio Therapeutics Appoints Leading Pharmaceutical and Regulatory Executives to its Board of Directors
29/07/2021 — WALTHAM, Mass, — (BUSINESS WIRE) Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, […]
Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets
26/07/2021 — WALTHAM, Mass. — (BUSINESS WIRE) Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, […]
Adagio Therapeutics Appoints David Hering, Global COVID-19 Vaccine Expert, as Chief Operating Officer
19/07/2021 — WALTHAM, Mass. — (BUSINESS WIRE) Adagio Therapeutics, Inc., a biotechnology company developing highly differentiated antibodies to broadly neutralize coronaviruses, today announced that David Hering has been appointed as […]
Greek National Organization of Medicines Approves First Antimicrobial Formula for Residual Surface Protection Against SARS-CoV-2 (COVID-19 Virus) for up to 90 Days
US-Greek Partnership to Commercialize BIOPROTECT™ RTU to Meet Growing European Demand and Expand Demand outside the United States 14/07/2021 — PHILADELPHIA — (BUSINESS WIRE) ViaClean Technologies, LLC, a Philadelphia-based biotech […]
Anna Biosciences Launches Pioneering Immunotherapeutic Treatment to Fight COVID-19
22/06/2021 — DUBLIN — (BUSINESS WIRE) Anna Biosciences, a drug discovery company focused on novel therapies in immuno-oncology, virology, and neurodegenerative diseases, today announces its entry in the fight against […]
Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), to be Special Guest Speaker at Everbridge COVID-19: Road to Recovery (R2R) Executive Summit, May 26-27, 2021
WHO Director-General Joins 42nd United States President Bill Clinton, Publishing Icon Steve Forbes, former United States Secretary of State Dr. Madeleine K. Albright, and C-Level Leaders from the Centers for […]
Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate
Similar antibody response in adults and in the elderly after two doses Neutralizing antibody responses were 10 times higher than people recovering from COVID-19 No related severe adverse events reported […]
Adagio Therapeutics Announces $336 Million Series C Financing to Support Rapid Advancement of Novel ADG20 #Antibody for the Treatment and Prevention of #COVID-19
Additional Capital to Fund Ongoing STAMP Pivotal Trial of ADG20 Designed to Support Emergency Use Authorization Submission Financing Follows First Quarter Appointment of Industry and Banking Veteran Jane Henderson as […]
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
Exclusive agreement for region brings GenScript’s innovative cPass™ kit to Spain, Portugal and Andorra 14/04/2021 — LEIDEN, Netherlands & BILBAO, Spain — (BUSINESS WIRE) GenScript Biotech (Netherlands) BV, a subsidiary […]
Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19
Phase 1/2/3 STAMP Trial to be Conducted Globally, Including in Countries with High Rates of SARS-CoV-2 Variants Resistant to Other Monoclonal Antibody Products Potential for Early Access to Therapy by […]
Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate
Trial to enroll up to 30,000 volunteers worldwide Fast Track designation granted by US FDA Feasibility study initiated of a vaccine candidate to address emerging variants 16/03/2021 — QUEBEC CITY […]
XPRIZE and Cognizant Announce Grand Prize Winners in Pandemic Response Challenge to Restart Economies Around the World
Winning AI models from VALENCIA IA4COVID19 of Spain and JSI vs COVID of Slovenia will help support decision-makers in determining pandemic intervention policies to safely reopen society 09/03/2021 — LOS […]
Mawi DNA’s Extractionless Sample Collection Technology Enables BioTech Africa Launch of Affordable COVID-19 Mass Testing Platform
25/01/2021 — HAYWARD, Calif. — (BUSINESS WIRE) Mawi DNA Technologies’ iSWAB-Microbiome-EL sample collection technology enables BioTech Africa to implement and launch a new ultra-high throughput COVID-19 testing program. This breakthrough, […]
EUROIMMUN Launches Novel ELISA for Detection of #SARS-CoV-2 Antigen in Acutely Infected Patients
Automatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus 16/12/2020 — WALTHAM, Mass. — (BUSINESS WIRE) EUROIMMUN, a PerkinElmer, Inc. Company, today […]
Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer
Recommendation based on positive results from the DESTINY-Breast01 trial, which showed durable responses in patients with previously treated disease 11/12/2020 — TOKYO & MUNICH — (BUSINESS WIRE) Daiichi Sankyo Company, […]